Covered recipient · General Payments record
ASHLEY JF BRANDON
Allopathic & Osteopathic Physicians Urology
General Payments · PY2018–2024
$3,998.04
- Reported across 216 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $317.71 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Sumitomo Pharma America, Inc. | $45.15 | 2 |
| Antares Pharma, Inc. | $44.74 | 2 |
| Janssen Biotech, Inc. | $41.30 | 2 |
| TOLMAR, INC. | $39.93 | 2 |
| Calyxo, Inc. | $30.40 | 1 |
| PFIZER INC. | $25.63 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $24.39 | 1 |
| Endo USA, Inc. | $19.50 | 1 |
| Merck Sharp & Dohme Corporation | $17.62 | 1 |
| COLOPLAST CORP | $14.84 | 1 |
| Photocure Inc | $14.21 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Antares Pharma, Inc. | $23.11 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146450505 | CMS |
| Antares Pharma, Inc. | $21.63 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146450509 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $24.39 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086126014 | CMS |
| Calyxo, Inc. | $30.40 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1099415940 | CMS |
| COLOPLAST CORP | $14.84 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117448300 | CMS |
| Endo USA, Inc. | $19.50 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138577968 | CMS |
| Janssen Biotech, Inc. | $16.99 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078817954 | CMS |
| Janssen Biotech, Inc. | $24.31 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078817784 | CMS |
| Merck Sharp & Dohme LLC | $17.62 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141571887 | CMS |
| PFIZER INC. | $25.63 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132134281 | CMS |
| Photocure Inc | $14.21 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119774063 | CMS |
| Sumitomo Pharma America, Inc. | $22.07 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148831049 | CMS |
| Sumitomo Pharma America, Inc. | $23.08 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148831051 | CMS |
| Tolmar, Inc. | $17.30 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138713118 | CMS |
| Tolmar, Inc. | $22.63 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138702589 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.